Clinical Trial Update: Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update examining how gut microbiota relates to outcomes in brain metastasis from non-small cell lung cancer treated with pembrolizumab plus chem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Xiaorong Dong | Conditions: Gut Microbiota, NSCLC | Phase 1, Phase 2 | Status: UNKNOWN